CBD Blocked a Tumor Immune Escape Molecule for the First Time in Cancer Cells

Both pure CBD and a high-CBD cannabis extract reduced cell proliferation and migration, increased apoptosis, and significantly downregulated HLA-G expression at mRNA and protein levels in JEG-3 choriocarcinoma cells. The HLA-G suppression was dose- and time-dependent and fully reversible after treatment withdrawal, indicating active CBD-dependent modulation rather than permanent cell damage.

JEG-3 human choriocarcinoma cells were treated with CBD and a high-CBD extract at safe concentrations determined by MTT assays. Researchers measured apoptosis (caspase-3), proliferation (Ki-67), migration (wound healing, MMP-9), and HLA-G expression (RT-qPCR and immunocytochemistry).

HLA-G is a key immune checkpoint molecule that helps tumors evade immune detection. This is the first experimental evidence that CBD can suppress HLA-G, suggesting a mechanism by which CBD could help the immune system recognize and attack tumors.

Immune checkpoint inhibitors have revolutionized cancer treatment. If CBD can suppress HLA-G, it could potentially complement existing immunotherapy approaches. The reversibility of the effect suggests ongoing CBD administration would be needed to maintain immune visibility of tumors.

Single cell line study (JEG-3 choriocarcinoma). Results may not extend to other tumor types. In vitro conditions do not replicate the complexity of the tumor microenvironment. The concentrations used may not be achievable in clinical settings.